Center for Translational Molecular Medicine (CTMM) is dedicated to the development of medical technologies that enable the design of new and 'personalized' treatments for the main causes of mortality and diminished quality of life (cancer and cardiovascular diseases and, to a lesser extent, neurodegenerative and infectious/autoimmune diseases) and the rapid translation of these treatments to the patient.
CTMM is a public-private consortium that comprises a multidisciplinary group of parties – universities, academic medical centers, medical technology enterprises and chemical and pharmaceutical companies.

CTMM is built on the foundations of former initiatives "Translational Cancer Research" (Privilege) and the Center for Molecular Medicine.

CTMM headquarters are located at the High Tech Campus in Eindhoven, The Netherlands.